ENDPOINTS NEWS38m
Sage turns down Bio­gen's buy­out of­fer and will look at oth­er op­tions
Sage Therapeutics rejects Biogen's $469M buyout offer. CEO Barry Greene and board seek alternatives, with Goldman Sachs ...
ENDPOINTS NEWS53m
Bris­tol My­ers shares IO com­bo da­ta in col­orec­tal can­cer; Pfiz­er still wait­ing on Braftovi reg­i­men sur­vival fig­ures
Several drugmakers shared new clinical data at this year’s ASCO GI Symposium in San Francisco, and Endpoints News has rounded ...
ENDPOINTS NEWS1h
Trump 2.0 blog: RFK con­fir­ma­tion hear­ings this week; Fed­er­al re­turn-to-of­fice is com­ing
Live news updates on the Trump administration's healthcare, pharma and biotech policies as the new government transitions ...